Ontology highlight
ABSTRACT:
SUBMITTER: Gantner P
PROVIDER: S-EPMC6481866 | biostudies-other | 2019
REPOSITORIES: biostudies-other
Gantner Pierre P Sylla Babacar B Morand-Joubert Laurence L Frange Pierre P Lacombe Karine K Khuong Marie-Aude MA Duvivier Claudine C Launay Odile O Karmochkine Marina M Arvieux Cédric C Ménard Amélie A Piroth Lionel L Canestri Ana A Trias Dominique D Peytavin Gilles G Landman Roland R Ghosn Jade J
PloS one 20190424 4
<h4>Introduction</h4>Limited "real life" data on raltegravir (RAL) use during pregnancy are available. Thus, we aimed at describing effectiveness and safety of RAL-based combined antiretroviral therapy (cART) in this setting.<h4>Methods</h4>HIV-1-infected women receiving RAL during pregnancy between 2008 and 2014 in ten French centers were retrospectively analysed for: (1) proportion of women receiving RAL anytime during pregnancy who achieved a plasma HIV-RNA (pVL) < 50 copies/mL at delivery, a ...[more]